Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 88 results found. Search for [ pharmaceutical firms ]

Results 1 to 21 of 88
BusinessToday.In
May 28, 2018
In 2013, the Ministry of Industry and Information Technology of China had valued country's IT market valued at over USD 493 billion. For India, getting access to China's IT market is important to address the massive trade deficit which has now crossed over USD 51 billion.


PTI
May 14, 2018



Ameera Shah
New Delhi, January 28, 2018
The healthcare sector is poised for an eventful 2018, as medical and pharmaceutical firms await key policy announcements.


PTI
December 16, 2017



Mail Today Bureau
New Delhi, June 28, 2017
Ahead of the GST rollout on July 1, the National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices of 761 medicines which includes a list of antibiotics and drugs for treating cancer, HIV, diabetes.


Reuters
February 9, 2017
With no more orders for the F-16 from the Pentagon, Lockheed plans to use its Fort Worth, Texas plant instead to produce the fifth generation F-35 Joint Strike Fighter that the United States Air Force is transitioning to.


PTI
New Delhi, January 24, 2017
The Indian Drug Manufacturers Association, a body comprising mostly home-grown pharma firms, said all excisable goods used for R&D purposes should be exempted from central excise duty.


By E. Kumar Sharma,E Kumar Sharma
Delhi, October 29, 2016
Many major pharma stocks, seen as safe bets in the worst of times, have seen their market caps slip in the past year. Is pharma losing its sheen on the bourses?


E Kumar Sharma
October 10, 2016
Leading global consultancy firms like Lachman Consultants, Parexel and Quintiles (now QuintilesIMS), have been in demand in India with pharmaceutical companies seeking their services to resolve regulatory compliance issues.


PTI
September 4, 2016
The mega trade deal TPP, which includes the US and 11 other countries, is likely to have \"serious implications\" on the growth of domestic pharma industry, particularly the generic market, a study said.


Joe C Mathew
July 7, 2016
Ireland's Investment Development Agency (IDA) is the counterpart of the Department of Industrial Policy and Promotion (DIPP) of India. The key mandate of both the organisations is to attract foreign direct investments (FDI).


PTI
New Delhi, June 10, 2016
Currently, FDI up to 100 per cent is permitted in new projects in the pharmaceutical sector, but in brownfield ones-the existing companies-the foreign investment is permitted through FIPB approval.


PTI
New Delhi, June 6, 2016
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.


PTI
New Delhi, May 6, 2016
The government is taking a number of initiatives to help pharma firms upgrade technology and promote drug discovery and innovation in the country, Parliament was informed on Friday.


PTI
New Delhi, April 26, 2016
The National Pharmaceutical Pricing Authority (NPPA) has issued notices to 263 firms that were found overcharging during 2015-16, Parliament was informed on Tuesday.


By E. Kumar Sharma
Delhi, April 25, 2016
In the third quarter, Dr. Reddy's revenues from India rose 34 per cent from the corresponding quarter of the previous year (partly due to acquisition of a few established brands of Belgian company UCB in India). However, in March, the growth was 7 per cent.


Reuters
April 1, 2016
Shortages of essential drugs, mostly generic medicines whose patents have long expired, are becoming increasing frequent globally, prompting the World Health Organization (WHO) to suggest minimum prices may be needed to keep some products on the market.


Ajay Tyagi and Munish Shekhavat
New Delhi, December 23, 2015
Globally also, it remained a year marked with record mergers, led by the $160 billion deal between Viagra maker Pfizer Inc and Botox manufacturer Allergan.


Reuters
Karen Rebelo and Zeba Siddiqui, December 22, 2015
Heavyweight generics makers, led by Sun Pharma and Dr Reddy's Laboratories, have long been seen as a conservative bet for domestic and foreign funds eyeing India.


IANS
New Delhi, November 6, 2015
\"The union Cabinet, chaired by Prime Minister Narendra Modi, has approved $750-million FDI in Mylan Laboratories Ltd by Mylan Group through equity shares or convertible debentures for acquiring entire shareholding of Jai Pharma Ltd (JPL),\" an official statement said in New Delhi.


PAGES 1 OF 5  12345